These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Evaluation of Polo-like kinase 1 as a potential therapeutic target in Merkel cell carcinoma. Kadletz L; Bigenzahn J; Thurnher D; Stanisz I; Erovic BM; Schneider S; Schmid R; Seemann R; Birner P; Heiduschka G Head Neck; 2016 Apr; 38 Suppl 1():E1918-25. PubMed ID: 26713885 [TBL] [Abstract][Full Text] [Related]
7. Basal cell carcinoma: CD56 and cytokeratin 5/6 staining patterns in the differential diagnosis with Merkel cell carcinoma. Panse G; McNiff JM; Ko CJ J Cutan Pathol; 2017 Jun; 44(6):553-556. PubMed ID: 28403527 [TBL] [Abstract][Full Text] [Related]
8. Avelumab: a new standard for treating metastatic Merkel cell carcinoma. Baker M; Cordes L; Brownell I Expert Rev Anticancer Ther; 2018 Apr; 18(4):319-326. PubMed ID: 29482384 [TBL] [Abstract][Full Text] [Related]
9. Complete spontaneous regression of primary Merkel cell carcinoma with tumoural infiltration: a systematic review. Ah-Thiane L; Samimi M; Kervarrec T; Khammari A; Dréno B Eur J Dermatol; 2021 Jun; 31(3):381-391. PubMed ID: 34080974 [TBL] [Abstract][Full Text] [Related]
10. Preparation and anti-cancer evaluation of promiximab-MMAE, an anti-CD56 antibody drug conjugate, in small cell lung cancer cell line xenograft models. Yu L; Yao Y; Wang Y; Zhou S; Lai Q; Lu Y; Liu Y; Zhang R; Wang R; Liu C; Gou L; Chen X; Yu Y; Chen Q; Yang J J Drug Target; 2018 Dec; 26(10):905-912. PubMed ID: 29630426 [TBL] [Abstract][Full Text] [Related]
11. ABCB5-Targeted Chemoresistance Reversal Inhibits Merkel Cell Carcinoma Growth. Kleffel S; Lee N; Lezcano C; Wilson BJ; Sobolewski K; Saab KR; Mueller H; Zhan Q; Posch C; Elco CP; DoRosario A; Garcia SS; Thakuria M; Wang YE; Wang LC; Murphy GF; Frank MH; Schatton T J Invest Dermatol; 2016 Apr; 136(4):838-846. PubMed ID: 26827764 [TBL] [Abstract][Full Text] [Related]
12. Recent Therapeutic Advances and Change in Treatment Paradigm of Patients with Merkel Cell Carcinoma. Garcia-Carbonero R; Marquez-Rodas I; de la Cruz-Merino L; Martinez-Trufero J; Cabrera MA; Piulats JM; Capdevila J; Grande E; Martin-Algarra S; Berrocal A Oncologist; 2019 Oct; 24(10):1375-1383. PubMed ID: 30962295 [TBL] [Abstract][Full Text] [Related]
14. T-Cell Responses in Merkel Cell Carcinoma: Implications for Improved Immune Checkpoint Blockade and Other Therapeutic Options. Gehrcken L; Sauerer T; Schaft N; Dörrie J Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445385 [TBL] [Abstract][Full Text] [Related]
15. Growth and characterization of a cell line from a human primary neuroendocrine carcinoma of the skin (Merkel cell carcinoma) in culture and as xenograft. Krasagakis K; Almond-Roesler B; Geilen C; Fimmel S; Krengel S; Chatzaki E; Gravanis A; Orfanos CE J Cell Physiol; 2001 Jun; 187(3):386-91. PubMed ID: 11319762 [TBL] [Abstract][Full Text] [Related]
16. CD70 antibody-drug conjugate as a potential therapeutic agent for uterine leiomyosarcoma. Nakae R; Matsuzaki S; Serada S; Matsuo K; Shiomi M; Sato K; Nagase Y; Matsuzaki S; Nakagawa S; Hiramatsu K; Okazawa A; Kimura T; Egawa-Takata T; Kobayashi E; Ueda Y; Yoshino K; Naka T; Kimura T Am J Obstet Gynecol; 2021 Feb; 224(2):197.e1-197.e23. PubMed ID: 32822640 [TBL] [Abstract][Full Text] [Related]
17. PD-L1 blockade with avelumab: A new paradigm for treating Merkel cell carcinoma. Barkdull S; Brownell I Cancer Biol Ther; 2017 Dec; 18(12):937-939. PubMed ID: 29172995 [TBL] [Abstract][Full Text] [Related]
18. Cytological and Immunocytochemical Features of Merkel Cell Carcinoma on Fine Needle Cytology Samples: A Study of 22 Cases. Cipolletta Campanile A; Malzone MG; Sanna V; Barizzi J; Manna A; Gioioso A; De Chiara A; Fulciniti F Endocr Pathol; 2015 Sep; 26(3):243-9. PubMed ID: 25982258 [TBL] [Abstract][Full Text] [Related]